Reitz; David B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reitz; David B..The latest application filed is for "pyrazoline compounds".

Company Profile

0.32.32

Reitz; David B. - Chesterfield MO
Reitz, David B. - St. Louis MO
Reitz; David B - Chesterfield MO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrazoline Compounds App 20120035131 - Meyers; Marvin J. ; et al.	2012-02-09
Pyrazoline Compounds App 20100280016 - Meyers; Marvin J. ; et al.	2010-11-04
Pyrazoline compounds Grant 7,781,428 - Meyers , et al. August 24, 2	2010-08-24
Pyrazoline Compounds App 20080167294 - Meyers; Marvin J. ; et al.	2008-07-10
Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension Grant 7,132,437 - Reitz , et al. November 7, 2	2006-11-07
Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade Grant 7,119,094 - South , et al. October 10, 2	2006-10-10
3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents Grant 7,030,153 - Talley , et al. April 18, 2	2006-04-18
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade App 20050153965 - South, Michael S. ; et al.	2005-07-14
Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors App 20050143371 - Meyers, Marvin J. ; et al.	2005-06-30
Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors App 20050137220 - Anderson, David R. ; et al.	2005-06-23
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade Grant 6,908,919 - South , et al. June 21, 2	2005-06-21
Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors App 20050101623 - Meyers, Marvin J. ; et al.	2005-05-12
Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides Grant 6,875,877 - Li , et al. April 5, 2	2005-04-05
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade App 20050043313 - South, Michael S. ; et al.	2005-02-24
1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders Grant 6,858,636 - Reitz , et al. February 22, 2	2005-02-22
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade Grant 6,828,338 - South , et al. December 7, 2	2004-12-07
Renal-selective biphenylalkyl 1H-substituted-1, 2, 4- triazole angiotensin I I antagonists for treatment of hypertension App 20040220245 - Reitz, David B. ; et al.	2004-11-04
Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds App 20040209897 - Vernier, William F. ; et al.	2004-10-21
Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake App 20040204478 - Lee, Len F. ; et al.	2004-10-14
Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake Grant 6,784,201 - Lee , et al. August 31, 2	2004-08-31
Substituted biphenyl compounds for the treatment of inflammation App 20040158074 - Reitz, David B. ; et al.	2004-08-12
Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 App 20040127492 - Vazquez, Michael L. ; et al.	2004-07-01
Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension App 20040121989 - Reitz, David B. ; et al.	2004-06-24
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade App 20040102448 - South, Michael S. ; et al.	2004-05-27
Renal-selective prodrugs for control of renal smpathetic nerve activity in the treatment of hypertension App 20040101523 - Reitz, David B. ; et al.	2004-05-27
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade App 20040068113 - South, Michael S. ; et al.	2004-04-08
Combinations for cardiovascular indications App 20040058908 - Keller, Bradley T. ; et al.	2004-03-25
1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders App 20040048911 - Reitz, David B. ; et al.	2004-03-11
Novel benzothiepines having activity as inhibitors of lleal bile acid transport and taurocholate uptake App 20040014803 - Lee, Len F. ; et al.	2004-01-22
Substituted biphenyl compounds for the treatment of inflammation Grant 6,677,488 - Reitz , et al. January 13, 2	2004-01-13
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade App 20040006230 - South, Michael S. ; et al.	2004-01-08
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade App 20040002494 - South, Michael S. ; et al.	2004-01-01
Renal-selective prodrugs for control of renal sympathetic nerve activity in the treatment of hypertension App 20030220521 - Reitz, David B. ; et al.	2003-11-27
1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders Grant 6,630,497 - Reitz , et al. October 7, 2	2003-10-07
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade Grant 6,624,180 - South , et al. September 23, 2	2003-09-23
3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents App 20030153602 - Talley, John J. ; et al.	2003-08-14
3,4-diaryl thiopenes and analogs thereof having use as antiinflammatory agents Grant 6,599,934 - Talley , et al. July 29, 2	2003-07-29
Substituted Polycyclic Aryl And Heteroaryl Pyridines Useful For Selective Inhibition Of The Coagulation Cascade App 20030139401 - South, Michael S. ; et al.	2003-07-24
3,4-diaryl thiophenes and analogs thereof having use as anti-inflammatory agents App 20030013744 - Talley, John J. ; et al.	2003-01-16
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade App 20020198199 - South, Michael J. ; et al.	2002-12-26
Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides App 20020188119 - Li, Jinglin ; et al.	2002-12-12
3,4-Diaryl Thiophenes and analogs thereof having use as antiflammatory agents App 20020058691 - TALLEY, JOHN J. ; et al.	2002-05-16
Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake Grant 6,387,924 - Lee , et al. May 14, 2	2002-05-14
Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides Grant 6,369,220 - Li , et al. April 9, 2	2002-04-09
1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders App 20020038035 - Reitz, David B. ; et al.	2002-03-28
Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake App 20020013476 - Lee, Len F. ; et al.	2002-01-31
N-substituted-1, 2, 4-triazolone compounds for treatment of cardiovascular disorders App 20010020100 - Manning, Robert E. ; et al.	2001-09-06
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake Grant 6,262,277 - Lee , et al. July 17, 2	2001-07-17
Substituted 5-aryl-benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake Grant 6,107,494 - Lee , et al. August 22, 2	2000-08-22
Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake Grant 5,994,391 - Lee , et al. November 30, 1	1999-11-30
Substituted terphenyl compounds for the treatment of inflammation Grant 5,739,166 - Reitz , et al. April 14, 1	1998-04-14
Carbamic acid derivatives of substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use Grant 5,677,296 - Chrusciel , et al. October 14, 1	1997-10-14
Substituted dibenzoxazepine and dibenzthiazepine carbamate compounds, pharmaceutical composition and methods of use Grant 5,504,077 - Collins , et al. April 2, 1	1996-04-02
N-substituted N-(.alpha.-triazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders Grant 5,484,937 - Bovy , et al. January 16, 1	1996-01-16
Use of N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders Grant 5,441,970 - Reitz , et al. August 15, 1	1995-08-15
Substituted dibenzoxazepine and dibenzthiazepine carbamate compounds, pharmaceutical compositions and methods of use Grant 5,441,950 - Collins , et al. August 15, 1	1995-08-15
Substituted spiro compounds for the treatment of inflammation Grant 5,393,790 - Reitz , et al. February 28, 1	1995-02-28
1,2 diarylcyclopentenyl compounds for the treatment of inflammation Grant 5,344,991 - Reitz , et al. September 6, 1	1994-09-06
N-substituted imidazol-2-one compounds for treatment of circulatory disorders Grant 5,238,952 - Reitz , et al. August 24, 1	1993-08-24
Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension Grant 5,217,985 - Reitz , et al. June 8, 1	1993-06-08
N-substituted N-(alpha-triazolyl-toluyl)pyrrole compounds and use for treatment of circulatory disorders Grant 5,175,180 - Bovy , et al. December 29, 1	1992-12-29
1H-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders Grant 5,098,920 - Reitz March 24, 1	1992-03-24
N-substituted imidazol-2-one compounds for treatment of circulatory disorders Grant 5,087,634 - Reitz , et al. February 11, 1	1992-02-11
Process for the preparation of N-substituted aminomethylphosphonic acids Grant 4,804,499 - Miller , et al. February 14, 1	1989-02-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.